Incontinence-Associated Dermatitis in Canadian LTC: Prevention and Product Selection

Quick Summary: Incontinence-associated dermatitis (IAD) is one of the most common skin problems in Canadian long-term care, and it is largely preventable with the right product and care routine. This guide explains what IAD is, why brief selection matters, how absorbency ratings translate to skin protection, and what LTC directors of care should look for when choosing incontinence products. Read time: 8 minutes.

1. What IAD Is and Why It Is Common in LTC

Incontinence-associated dermatitis is inflammation of the skin caused by repeated or prolonged contact with urine or stool. The moisture softens the stratum corneum, the skin becomes more permeable, and the combination of wetness, friction, and irritants in urine and faeces breaks down the skin barrier. In severe cases, the skin can blister or become infected, and IAD can be mistaken for — or coexist with — pressure injuries.

In Canadian long-term care homes, the prevalence is high. Incontinence affects a majority of residents at some point during their stay, and staff who care for these residents deal with wet skin, frequent changes, and the constant risk of breakdown. IAD matters not only for resident comfort and dignity but also for clinical outcomes: damaged skin is more vulnerable to fungal and bacterial infection, and it complicates the management of residents who are already medically fragile.

The numbers behind the condition are sobering for a director of care. Incontinent residents who develop IAD require additional nursing time for assessment, cleansing, barrier application, and monitoring — time that comes out of the same staffing pool that provides toileting, meals, and medication administration. Facilities that treat IAD as a routine cost of incontinence are effectively accepting a preventable clinical complication as a permanent budget line. Facilities that track skin condition systematically, with a simple tool at each change, catch the first signs of maceration before they become an injury.

2. The Difference Between IAD and Pressure Injuries

IAD is frequently confused with pressure injuries (pressure ulcers), but they are different conditions with different prevention strategies.

A resident can have both conditions at the same time, and IAD increases the risk of pressure injury because damaged skin is less resilient. This is why an incontinence care protocol is not just a hygiene program — it is a pressure injury prevention program too.

3. How the Right Brief Prevents IAD

The brief (adult diaper) is the first line of defense between moisture and skin. The key properties that matter for IAD prevention:

• Absorbency — a brief that absorbs and locks away urine quickly keeps moisture off the skin. Absorbency is measured in millilitres (mL), and higher-rated briefs are designed for heavier output or longer wear.
• Wetness indicator — a color-change strip that tells staff when a change is needed without disturbing the resident. This reduces how often skin is exposed unnecessarily and catches wetness earlier.
• Breathable backsheet — a material that lets moisture vapor escape reduces the warm, damp microclimate that encourages skin breakdown.
• Skin-friendly core — a fast-wicking acquisition layer and absorbent core with a soft surface layer that stays drier against the skin.
• Barrier properties — leg cuffs and waistbands that contain leaks, because leaked urine on bedding or clothing creates a second round of skin exposure.

4. Absorbency Ratings Explained: What the mL Number Means

Canadian buyers see briefs rated in millilitres — 2,000 mL, 3,000 mL, 5,000 mL. The number refers to the manufacturer's tested absorbent capacity of the product, measured under laboratory conditions. It is a useful comparison tool, but it is not a guarantee of how long a brief will last on a given resident; real-world output varies, and fit, position, and frequency of changing all matter.

The clinical principle is: choose a brief whose absorbency matches the resident's output and the realistic change schedule. A resident who is changed every two hours needs less absorbency than one changed twice a night. Over-absorbent products are more expensive; under-absorbent products leave skin wet and increase IAD risk. Matching matters.

For day use in LTC, a 3,000 mL brief such as CliniEco Medical's Day Comfort adult incontinence briefs (3,000 mL, 60-pack) covers the moderate-to-heavy range that most residents fall into. Facilities also use standard 60-pack briefs in M–L sizing for residents whose output is lighter, reserving the higher-rated products for overnight and high-output residents. Keeping two or three absorbency tiers in stock lets staff match the product to the resident instead of forcing one product to fit everyone.

5. The Care Protocol Around the Product

No product prevents IAD by itself. The evidence-based approach to IAD prevention combines product choice with a consistent care routine:

1. Cleanse — clean the skin at every change with a gentle cleanser or disposable washcloth; avoid vigorous rubbing.
2. Protect — apply a skin barrier product (cream or film) to protect intact skin from moisture and irritants.
3. Contain — use a well-fitted brief with adequate absorbency and leak protection to keep moisture away from skin.
4. Reposition — reposition residents regularly per facility policy; this also helps prevent pressure injuries.

Canadian LTC homes should have a written continence care policy that covers these steps, and it should be consistent across shifts. The product is part of the protocol, not the whole protocol.

6. What Directors of Care Should Look For When Choosing Briefs

Procurement for LTC is a balancing act between clinical outcomes, resident dignity, and budget. A director of care evaluating incontinence briefs should look at:

• Absorbency range — does the product line cover day, heavy, and overnight needs? A single SKU that tries to do everything usually does none of them well.
• Wetness indicator reliability — the indicator should be visible and accurate; this is a staff-time saver.
• Fit range — sizes from M to XL+ and adjustable fasteners matter for dignity and leak prevention.
• Documentation — supplier should provide product specifications and testing data.
• Supply reliability — LTC homes cannot switch products weekly; a stable, stocked supplier is a clinical requirement, not a convenience.

Cost per resident-day is the metric directors of care should track, not cost per pack. A 60-pack of 3,000 mL briefs used over six changes per day covers roughly ten resident-days; an overnight 60-pack covers closer to two months for a single resident. When the numbers are worked out that way, the higher-priced overnight product is often the more economical choice, because it reduces the number of night-time changes, the risk of skin damage, and the extra supplies those complications consume.

There is also a hidden labour cost in the wrong product. A brief that leaks shifts the workload onto bedding changes, laundry, and skin care after the fact. A facility that under-specifies absorbency to save a few cents per brief frequently pays for it in staff hours and resident outcomes. This is why product trials matter: run a two-week trial with the shortlisted briefs on a representative unit, measure changes per resident-day, leakage incidents, and skin condition, and use that data — not the price list — to make the final decision.

7. Night Care: The Overnight Strategy

Overnight care is where IAD risk is highest: residents are changed less often, they sleep through leakage, and the skin is exposed to moisture for hours. The standard strategy is a dedicated overnight product with higher absorbency — often 5,000 mL or more — designed to hold output until morning while keeping the resident comfortable. CliniEco Medical's Night Plus adult incontinence briefs (5,000 mL, overnight, 60-pack) are built for this exact overnight window.

Night-time skin checks remain important even with a high-absorbency brief. If a resident is consistently wet in the morning despite a 5,000 mL product, the problem may be fit, positioning, or output volume — and the care plan, not just the product, needs review.

8. FAQ

Q1: What is incontinence-associated dermatitis (IAD)?

IAD is inflammation of the skin caused by repeated or prolonged contact with urine or stool. Moisture softens the skin barrier, irritants in urine and faeces cause inflammation, and friction worsens it. It is common in long-term care and largely preventable with the right care routine and products.

Q2: How is IAD different from a pressure injury?

IAD is caused by moisture and irritants, typically in the perineal area, and appears as diffuse redness and maceration. Pressure injuries are caused by pressure and shear over bony areas like the sacrum and heels. They can occur together, and IAD increases pressure injury risk.

Q3: What absorbency rating should an LTC home buy?

Match the rating to the resident and schedule: around 2,000 mL for light day use, 3,000 mL for moderate-to-heavy day use, and 5,000 mL or more for overnight. A product line that covers day and night needs gives staff the right tool for each resident.

Q4: Do wetness indicators really reduce IAD?

Yes, when used properly. A wetness indicator lets staff see when a change is needed without disturbing the resident, so skin is not left in contact with moisture unnecessarily. It also reduces unnecessary checks and supports consistent change routines.

Q5: Can a brief alone prevent IAD?

No. The evidence-based approach combines cleansing, barrier protection, containment with a well-fitted absorbent product, and repositioning. The product is one component of a written continence care protocol.

Q6: Why do LTC homes need a separate overnight brief?

Overnight, residents are changed less often and may sleep through leakage. A higher-absorbency overnight product (5,000 mL or more) holds output until morning, keeping skin dry and reducing IAD risk during the longest exposure window of the day.

Q7: How many changes per day is normal for an incontinent LTC resident?

It varies with output and product absorbency. With a 3,000 mL brief, 4–6 changes per 24 hours is typical; with a higher-absorbency overnight product, the morning change may be the first of the day. The wetness indicator and care plan determine the right cadence for each resident.

Q8: Where can Canadian LTC homes buy adult incontinence briefs in bulk?

Buy from suppliers with documented product specifications and stable stock. CliniEco Medical supplies adult incontinence briefs to Canadian LTC homes — Day Comfort 3,000 mL for day use and Night Plus 5,000 mL for overnight — in 60-pack case quantities, with consistent supply and transparent pricing.

9. Final Word for Directors of Care

IAD is preventable, and prevention starts with matching the product to the resident and the schedule. Choose briefs with absorbency that matches real output, use wetness indicators to keep change routines honest, run a consistent cleanse–protect–contain–reposition protocol across all shifts, and buy from a supplier that can document what it sells. Skin health in LTC is a product decision and a care decision — and both are manageable.

CliniEco Medical supplies adult incontinence briefs and skin-protection supplies to Canadian long-term care homes and home care agencies. If your facility is reviewing incontinence products or wants a bulk quote, contact our sales team — we support care teams across Canada with documented products and dependable supply. A closer look at this category is provided in managing incontinence through Canadian winters.

Last updated: August 17, 2026. This article is for general information and does not constitute medical, legal, or regulatory advice. Always follow your facility's continence care policy and clinical guidelines.

CliniEco Medical is a licensed medical device establishment (MDEL #35334).

decode HAI, SSI, CJD and MDRO acronyms in our infection control pillar article.

References

1. Canadian Continence Foundation. https://www.canadiancontinence.ca/
2. Wounds Canada. https://www.woundscanada.ca/
3. Public Health Agency of Canada. Infection prevention and control. https://www.canada.ca/en/public-health/services/infection-prevention-control.html
4. Health Canada. Medical devices — how devices are approved and authorized in Canada. https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices.html
5. World Health Organization. Infection prevention and control. https://www.who.int/teams/integrated-health-services/infection-prevention-control
6. Antimicrobial Resistance & Infection Control (Springer, open access). https://link.springer.com/journal/13756
7. Journal of Hospital Infection (Elsevier). https://www.sciencedirect.com/journal/journal-of-hospital-infection
8. American Journal of Infection Control (Elsevier). https://www.sciencedirect.com/journal/american-journal-of-infection-control
9. Infection Control & Hospital Epidemiology (Cambridge). https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology
10. Emerging Infectious Diseases (CDC). https://wwwnc.cdc.gov/eid/
11. CMAJ (Canadian Medical Association Journal). https://www.cmaj.ca/
12. MedPage Today. https://www.medpagetoday.com/
13. The Lancet Planetary Health. https://www.thelancet.com/lancet-planetary-health
14. Canadian Centre for Occupational Health and Safety (CCOHS). https://www.ccohs.ca/
15. Modern Healthcare. https://www.modernhealthcare.com/
16. Health Care Without Harm. https://noharm.org/